BOT-1712-IFNg-SD

N/A

Report date: 2022/06/28 09:42:32

Base Information

Drug NameBOT-1712-IFNg-SD
Drug Alias Name2nd Gen PDGFRB sdAB BOT1712-IFNG-SDBOT-1712-IFNg-SD
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionPlatelet-derived growth factor receptor beta agonists
TargetsPlatelet-derived growth factor receptor beta
Therapy Area/IndicationsLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiorion Technologies
China Registration ClassN/A

Develop Information

Active CompaniesBiorion Technologies
Inactive CompaniesN/A
Active IndicationsLiver Cirrhosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A